Background free in vivo 29 Si MR imaging with hyperpolarized PEGylated silicon nanoparticles.
Seung-Hyun YangJiwon KimTae Geol LeeMirae ParkHye Young SonChan Gyu JooJeong Hyun ShimSeunghyun LeeYong-Min HuhPublished in: The Analyst (2023)
This study demonstrated the potential of 50 nm PEGylated Si NPs for high-resolution in vivo 29 Si MR imaging, emphasizing their biocompatibility and water dispersibility. The acquisition of in vivo Si MR images using the lowest reported dose after subcutaneous and intraperitoneal administration opens new avenues for future 29 Si MR studies.